Premium
Age‐related changes in the glycosaminoglycans of human meniscal aggrecan
Author(s) -
AlJafary Meneerah,
Huckerby Thomas N.,
Lauder Robert M.
Publication year - 2004
Publication title -
international journal of experimental pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.671
H-Index - 72
eISSN - 1365-2613
pISSN - 0959-9673
DOI - 10.1111/j.0959-9673.2004.369bf.x
Subject(s) - aggrecan , glycosaminoglycan , cartilage , chemistry , meniscus , anatomy , proteoglycan , osteoarthritis , keratan sulfate , chondroitin sulfate , articular cartilage , pathology , medicine , physics , alternative medicine , incidence (geometry) , optics
Meniscal damage and degradation, which are strongly correlated with subsequent OA, have been identified in approximately 60% of people over 60 years of age. Age‐related changes in articular cartilage glycosaminoglycans (GAGs) have been described, and used to facilitate the study of pathology‐related changes (Plass et al . 1998). However, such data do not yet exist for the meniscus. Materials and methods Undamaged human menisci were obtained following leg amputations, and the vascular and avascular zones of each lateral and medial meniscus were extracted into 4 m GuHCl. Aggrecan was recovered in the A1 fraction following CsCl density gradient centrifugation, and the relative abundance of chondroitin, dermatan and keratan sulphates (CS, DS and KS) was examined by NMR spectroscopy at 400 MHz and 43 °C. Results Human meniscal aggrecan was shown to contain CS, DS and KS, and our data show age‐related changes in the relative abundance of these GAGs. The change was similar for medial and lateral menisci and for the vascular and avascular zones within these. The KS abundance in aggrecan from young menisci (<15 years) was found to be 15–20% of the total GAGs. However, in older samples, it comprised only 7–12% of the GAGs. We have confirmed the presence of DS in human meniscal aggrecan and show that the abundance of DS gradually falls from approximately 16% at 10 years to 2–4% at 75 years. There is some variability between humans, although the trend is clear and for each human there is good agreement between medial and lateral menisci and vascular and avascular locations. The levels of CS comprise the remainder of the GAG attached to aggrecan and contribute the remainder of the GAG abundance. This can be seen to increase from 67 to 72% at 10 years to approximately 90% at 75 years. Discussion Our data show a clear age‐related change in the relative abundance CS, DS and KS from human meniscal aggrecan. The data show a decrease in the abundance of KS and DS and a concomitant increase in CS levels. These observations differ from those widely seen for articular cartilage, in which the levels of CS are seen to fall with age. We have confirmed that DS is a component of human meniscal aggrecan in agreement with previous work (McNicol & Roughley 1980). However, previously reported levels of DS, approximately 20%, are those found only in younger menisci. Absolute levels of these GAGs have not yet been determined, and hence the mechanisms which bring about this relative increase in CS with age may include either changes in biosynthetic output and/or widespread GAG loss in which KS and DS loss increases with age.